Key result
SARS-CoV-2 infection is associated with coronary plaque progression on CTA and worse cardiovascular outcomes.
Why the study?
Does SARS-CoV-2 infection increase coronary atherosclerotic plaque progression and adverse cardiovascular events?
Does SARS-CoV-2 infection increase coronary atherosclerotic plaque progression and adverse cardiovascular events?
SARS-CoV-2 infection is associated with accelerated coronary plaque progression and adverse cardiovascular outcomes.
Answers are grounded in this paper and cite their sources.
May warrant closer post-infection CV surveillance; extends observational links but leaves causality and practice change open.
SARS-CoV-2 infection was associated with coronary atherosclerotic plaque progression, as assessed by coronary CT angiography, and worse cardiovascular outcomes.
No takes yet. Share an insight, caveat, or question.
Dai et al. (2025) studied this question. SARS-CoV-2 infection was associated with coronary atherosclerotic plaque progression on CT angiography and worse cardiovascular outcomes.
Synapse has enriched 10 related papers. Consider them for comparative context: